| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
AI in Remote Patient Monitoring (RPM) Market – Global Forecast to 2030
The AI in remote patient monitoring market is projected to reach USD 8,438.5 million by 2030 from USD 1,967.7 million in 2024, at a high CAGR of 27.5% during the forecast period.
遠隔患者モニタリング（RPM）向けのAI市場は、予測期間中に 27.5% という高い CAGR で成長し、2024 年の 19 億 6,770 万ドルから 2030 年には 84 億 3,850 万ドルに達すると予測されています。
Reason for growth in the AI in remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. According to US CDC about 1 in 31 hospital patients has at least one healthcare-associated infection. For instance, the University of Pittsburgh Medical Center reported that RPM devices reduced hospital readmissions by 76%.
遠隔患者モニタリング市場における AI の成長理由: 血流感染症、尿路感染症、肺炎、クロストリジウム・ディフィシル感染症などの院内感染 (HAI) にかかる人が増えています。これらの感染症は、病院での重大な健康合併症や死亡に関連しているため、リスクの予防と管理には、患者を遠隔でモニタリングするソリューションが必要でした。さらに、心血管疾患、肥満、糖尿病などの慢性疾患の発生率が上昇しており、効果的な遠隔モニタリング技術の需要が高まっています。
米国の医療費は大幅に悪化しており、米国の成人のほぼ半数が処方薬や医師の診察を受けるのに苦労しています。米国 CDC によると、入院患者の約 31 人に 1 人が少なくとも 1 つの医療関連感染症にかかっています。たとえば、ピッツバーグ大学医療センターは、RPM デバイスによって入院再発が 76% 減少したと報告しています。
Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE HealthCare (US), Medtronic (Ireland), AliveCor, Inc. (US), NIHON KOHDEN CORPORATION (Japan), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), Beijing Choice Electronic Tech Co. Ltd (US), Biobeat (Israel), Biotronik (Germany), and AccurKardia, Inc. (US) are some of the key players in the AI in remote patient monitoring market.
The study includes an in-depth competitive analysis of these key players in the AI in remote patient monitoring market, with their company profiles, recent developments, and key market strategies.
The report provides insights on the following pointers:
- Analysis of key drivers (growing telehealth and remote patient monitoring markets, rising prevalence of chronic diseases, growing adoption of mhealth apps, increased government support and favorable reimbursement policies, growing awareness about lifestyle management and home healthcare) restraints (regulatory variations across regions, shortage of skilled professionals to operate AI based tools, and data security concerns) opportunities (growing in the demand for personalized medicine, increase in the partnership and collaboration among healthcare providers and AI based companies, growing opportunities in emerging nations, hospital-at-home, and rising investment in AI based RPM solutions) challenges (issues related to accuracy due to scarcity of high quality healthcare data, reluctance among healthcare professionals to adopt AI in remote patient monitoring, and lack of interoperability)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in remote patient monitoring market
- Market Development: Comprehensive information about lucrative markets – the report analyses the AI in remote patient monitoring market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in remote patient monitoring market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthare, Inc. (Japan), GE HealthCare (US), Boston Scientific Corporation (US), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), NIHON KOHDEN CORPORATION (Japan), and Biotronik (Germany); among others in the AI in remote patient monitoring market